Research and development
Flow – sum over the period · $M
Q4 FY2023
222a$M
derived
All values (16)
| Period | Value ($M) | Status |
|---|---|---|
| Q4 FY2026 | 266 | derived |
| Q3 FY2026 | 254 | reported |
| Q2 FY2026 | 258 | reported |
| Q1 FY2026 | 251 | reported |
| Q4 FY2025 | 269 | derived |
| Q3 FY2025 | 247 | reported |
| Q2 FY2025 | 240 | reported |
| Q1 FY2025 | 233 | reported |
| Q4 FY2024 | 248 | derived |
| Q3 FY2024 | 243 | reported |
| Q2 FY2024 | 229 | reported |
| Q1 FY2024 | 236 | reported |
| Q4 FY2023 | 222 | derived |
| Q3 FY2023 | 209 | reported |
| Q2 FY2023 | 204 | reported |
| Q1 FY2023 | 210 | reported |
28 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: rnd
More metrics for ADP
Income statement
Balance sheet
Cash flow
Debt and interest
Revenue by segment/product/region
Sources & calculation
- Value
- $222M (derived)
- Period
- Q4 FY2023, ended Jun 30, 2023 · quarterly value (3 months, not cumulative)
- Calculation
- Q4 = fiscal year − 9 months cumulative = 845M − 623M = $222M (FY value from 10-K 0000008670-24-000024; 9-month value from the Q3-10-Q)
- Source
- 10-K, filed Aug 7, 2024 · 0000008670-24-000024
- Location
- us-gaap:ResearchAndDevelopmentExpense
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $222M | Aug 7, 2024 | 10-K 0000008670-24-000024 | derived · confidence 1. · current |